Active-ingredient Dossier
Amlodipine Besilate
Active-ingredient Dossier for Amlodipine Besilate (calcium channel blocker). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: ARX-TELMISARTAN/AMLODIPINE
- Brand: GenRx
- Brand: EXFORGE
- Brand: APO-OLMESARTAN/AMLODIPINE/HCTZ
- Brand: COVERAM
- Brand: OLAMLO
- Therapeutic area: Cardiology
What is
Amlodipine Besilate Amlodipine Besilate is a calcium channel blocker.
Australian brands containing
Amlodipine Besilate — GenRx — TELMISARTAN/AMLODIPINE/VALSARTAN NOVARTIS — AMLODIPINE/VALSARTAN/HCT NOVARTIS — EXFORGE — AMLO — AMLODIPINE GH — AMLODIPINE SANDOZ — AMLODIPINE-WGR — AMLOZIC — APO-AMLODIPINE — APO-OLMESARTAN/AMLODIPINE/HCTZ
Therapeutic areas
Amlodipine Besilate is registered in cardiology (54 brands) and neurology (1 brand).
Sponsor landscape
The ingredient is marketed by 15 sponsors, including Arrotex Pharmaceuticals, Ipca Pharma, Alphapharm, Novartis Pharmaceuticals, Servier Laboratories (Aust) and Accord Healthcare.
PBS and regulatory activity
Two brands containing Amlodipine Besilate have PBAC outcomes on record, with the latest outcome dated 1 July 2020. Three brands have AusPARs on record, with the latest dated 26 July 2010.